Altamira Therapeutics Ltd (CYTO) stock is lower by -91.86% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives CYTO stock a score of 18 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 26. CYTO's rank also includes a long-term technical score of 27. CYTO has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on CYTO!